Table 4: Clinical benefit (CB) of the
patients (CR + PR + SD ≥ 6 months). CR: complete response; PR: partial
response; SD: stable disease.
|
|
N = 41 |
% |
|
CR |
1 (1 lasting more than 6 months) |
2.5% (2.5%) |
|
PR |
25 (11 lasting more than 6 months) |
61% (26.8%) |
|
SD |
15 (6 lasting more than 6 months) |
37% (14.7%) |
|
CB |
18 |
44% |